[go: up one dir, main page]

WO2000049043A3 - Human lipid-associated proteins - Google Patents

Human lipid-associated proteins Download PDF

Info

Publication number
WO2000049043A3
WO2000049043A3 PCT/US2000/004160 US0004160W WO0049043A3 WO 2000049043 A3 WO2000049043 A3 WO 2000049043A3 US 0004160 W US0004160 W US 0004160W WO 0049043 A3 WO0049043 A3 WO 0049043A3
Authority
WO
WIPO (PCT)
Prior art keywords
associated proteins
lipap
human lipid
provides
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/004160
Other languages
French (fr)
Other versions
WO2000049043A2 (en
Inventor
Y Tom Tang
Jennifer L Hillman
Henry Yue
Yalda Azimzai
Mariah R Baughn
Bao Tran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Pharmaceuticals Inc filed Critical Incyte Pharmaceuticals Inc
Priority to AU30012/00A priority Critical patent/AU3001200A/en
Priority to JP2000599780A priority patent/JP2002541772A/en
Priority to EP00908718A priority patent/EP1153035A2/en
Priority to CA002362300A priority patent/CA2362300A1/en
Publication of WO2000049043A2 publication Critical patent/WO2000049043A2/en
Publication of WO2000049043A3 publication Critical patent/WO2000049043A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention provides human lipid-associated proteins (LIPAP) and polynucleotides which identify and encode LIPAP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of LIPAP.
PCT/US2000/004160 1999-02-19 2000-02-18 Human lipid-associated proteins Ceased WO2000049043A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU30012/00A AU3001200A (en) 1999-02-19 2000-02-18 Human lipid-associated proteins
JP2000599780A JP2002541772A (en) 1999-02-19 2000-02-18 Human lipid-related protein
EP00908718A EP1153035A2 (en) 1999-02-19 2000-02-18 Human lipid-associated proteins
CA002362300A CA2362300A1 (en) 1999-02-19 2000-02-18 Human lipid-associated proteins

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12070399P 1999-02-19 1999-02-19
US60/120,703 1999-02-19
US14276299P 1999-07-08 1999-07-08
US60/142,762 1999-07-08

Publications (2)

Publication Number Publication Date
WO2000049043A2 WO2000049043A2 (en) 2000-08-24
WO2000049043A3 true WO2000049043A3 (en) 2001-02-01

Family

ID=26818670

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/004160 Ceased WO2000049043A2 (en) 1999-02-19 2000-02-18 Human lipid-associated proteins

Country Status (5)

Country Link
EP (1) EP1153035A2 (en)
JP (1) JP2002541772A (en)
AU (1) AU3001200A (en)
CA (1) CA2362300A1 (en)
WO (1) WO2000049043A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7972802B2 (en) 2005-10-31 2011-07-05 University Of Washington Lipoprotein-associated markers for cardiovascular disease
US8241861B1 (en) 2008-07-08 2012-08-14 Insilicos, Llc Methods and compositions for diagnosis or prognosis of cardiovascular disease

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472858A (en) * 1991-06-04 1995-12-05 Wisconsin Alumni Research Foundation Production of recombinant proteins in insect larvae
CA2200794A1 (en) * 1997-03-24 1998-09-24 The Governing Council Of The University Of Toronto Gene and protein related to alzheimer's disease
WO2000009688A1 (en) * 1998-08-12 2000-02-24 Kazusa Dna Research Institute Foundation Novel gene and protein osbh encoded thereby

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472858A (en) * 1991-06-04 1995-12-05 Wisconsin Alumni Research Foundation Production of recombinant proteins in insect larvae
CA2200794A1 (en) * 1997-03-24 1998-09-24 The Governing Council Of The University Of Toronto Gene and protein related to alzheimer's disease
WO2000009688A1 (en) * 1998-08-12 2000-02-24 Kazusa Dna Research Institute Foundation Novel gene and protein osbh encoded thereby

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200019, Derwent World Patents Index; AN 2000-224333, XP002144844 *
KOTANI ET AL.: "Homo spiens mRNA for KIAA0772 protein, complete cds.", EMBL SEQUENCE DATABASE, 17 November 1998 (1998-11-17), HEIDELBERG DE, XP002144842 *
KOTANI ET AL.: "KIAA0772 protein", EMBL SEQUENCE DATABASE, 1 November 1999 (1999-11-01), HEIDELBERG DE, XP002144843 *
NAGASE ET AL: "PREDICTION OF THE CODING SEQUENCES OF UNIDENTIFIED HUMAN GENES. XI.THE COMPLETE SEQUENCES OF 100 NEW CDNA CLONES FROM BRAIN WHICH CODEFOR LARGE PROTEINS IN VITRO", DNA RESEARCH, vol. 5, 1998, pages 277 - 286, XP002926060, ISSN: 1340-2838 *

Also Published As

Publication number Publication date
AU3001200A (en) 2000-09-04
JP2002541772A (en) 2002-12-10
CA2362300A1 (en) 2000-08-24
EP1153035A2 (en) 2001-11-14
WO2000049043A2 (en) 2000-08-24

Similar Documents

Publication Publication Date Title
WO2001012662A3 (en) Membrane associated proteins
WO1999061471A3 (en) Human transmembrane proteins
WO2000015793A3 (en) Human gpcr proteins
WO2000018922A3 (en) Human carbohydrate-associated proteins
WO2000034477A3 (en) Neuron-associated proteins
WO2000021988A3 (en) Human ankyrin family protein
WO1999058692A3 (en) Human apoptosis associated proteins
WO2000009709A3 (en) Proteases and associated proteins
WO2001020004A3 (en) Protein phosphatase and kinase proteins
WO2000026245A3 (en) Human membrane transport proteins
WO2000012703A3 (en) Protein transport-associated molecules
WO2000017355A3 (en) Human cytoskeleton associated proteins
WO2000014251A3 (en) Human transferase proteins
WO2000052151A3 (en) Human secretory proteins
WO2000078953A3 (en) Human transport proteins
WO2000044900A3 (en) Nucleic-acid binding proteins
WO2001044448A3 (en) Human oxidoreductase proteins
WO1999061614A3 (en) Human socs proteins
WO2000028045A3 (en) Human hydrolase proteins
WO2000042201A3 (en) Human peptidases
WO2000065054A3 (en) Human membrane-associated proteins
WO2000008155A3 (en) Human receptor-associated proteins
WO2000001821A3 (en) Neurotransmission associated proteins
WO2000078954A3 (en) Human transcriptional regulator proteins
WO2000060082A3 (en) Vesicle associated proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2362300

Country of ref document: CA

Ref country code: CA

Ref document number: 2362300

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2000908718

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 599780

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 2000908718

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000908718

Country of ref document: EP